Sustained release of antibacterial lipopeptides from biodegradable polymers against oral pathogens

Keyphrases

• Lipopeptide 100%
• Sustained Release 100%
• Biodegradable Polymers 100%
• Oral Pathogens 100%
• Antimicrobial Peptides 75%
• Antibiofilm 50%
• Biocompatibility 25%
• Mode of Action 25%
• Enzymatic Activity 25%
• Colorimetric Assay 25%
• Release Profile 25%
• Fluorescence-activated Cell Sorting 25%
• Ultrashort 25%
• Innate Immune Response 25%
• Cell Release 25%
• Antibacterial Drugs 25%
• Membrane Disruption 25%
• Oral Cavity 25%
• First Line of Defence 25%
• Fluorometric Assay 25%
• Polylactic Acid 25%
• Polymeric Formulations 25%
• Ricinoleic Acid 25%
• Aliphatic Acids 25%
• Alternatives to Antibiotics 25%
• Pathogenic Species 25%
• Antibacterial Biofilm 25%
• Salivary Flow 25%
• Live-dead Staining 25%
• Antibacterial Activity 25%
• Castor Oil Acid 25%
• Poly(ester-anhydride) 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Infectious Agent 100%
• Sustained Release 100%
• Antiinfective Agent 100%
• Lipopeptide 100%
• Polypeptide Antibiotic Agent 75%
• Biocompatibility 25%
• Antibacterial Activity 25%
• Fluorescence Activated Cell Sorting 25%
• Ricinoleic Acid 25%
• Antibiotic Agent 25%
• Acid Anhydride 25%
• Membrane Damage 25%
• Polylactic Acid 25%
• Castor Oil 25%
• Aliphatic Carboxylic Acid 25%

Immunology and Microbiology

• Infectious Agent 100%
• Sustained Drug Release 100%
• Antimicrobial Peptides 100%
• Biofilm 66%
• Innate Immune System 33%
• Antibacterial Activity 33%
• Enzyme Activity 33%
• Face 33%
• Fluorescence Activated Cell Sorting 33%
• Membrane Damage 33%
• Salivation 33%
• Lactic Acid 33%